Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 2

Status

Withdrawn 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 5NETWORK 3NIH 2

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3

Conditions

Hodgkin Disease 3Lymphoma 2

Interventions

Radiotherapy 138Cyclophosphamide 108Cisplatin 103Doxorubicin 99Vincristine 76Filgrastim 60Etoposide 58Paclitaxel 56Carboplatin 53Fluorouracil 51Methotrexate 49Dexamethasone 49Cytarabine 43Prednisone 42Leucovorin 40Granulocyte Colony-Stimulating Factor 34Docetaxel 34Radiation 31Specimen Handling 30Tamoxifen 27Daunorubicin 27Magnetic Resonance Spectroscopy 26Calcium Dobesilate 26Ifosfamide 25Mercaptopurine 24Gemcitabine 24Platinum 22Goserelin 221,2-diaminocyclohexaneplatinum II citrate 22Chemotherapy, Adjuvant 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × NETWORK × ABVD protocol × Clear all
NCT00005584 2025-08-05

Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Active not recruiting
1,649 enrolled
Lymphoid

Hodgkin Disease, Lymphoma

NCT00049595 2025-08-05

Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Completed
552 enrolled
Lymphoid

Hodgkin Disease, Lymphoma

NCT01652261 2021-02-15

H11

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Withdrawn
Lymphoid

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡